| abstract |
The present invention relates to a pharmaceutically stable crystalline form of (5,6-dimethyl-9-oxo-9H-xanthen-4-yl) acetic acid (DMXAA) sodium salt, a process for preparing such a stable crystalline form, A pharmaceutical composition comprising at least one such crystalline form in a solid or dissolved form and a pharmaceutically acceptable carrier, and optionally in combination with other active pharmaceutical preparations thereof for treating a tumor To methods of using such pharmaceutical compositions. [Selection figure] None |